Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg iito 600x60px
Document › Details

Apogenix AG. (5/4/16). "Press Release: Apogenix to Present at Two Upcoming International Conferences". Heidelberg.

Region Region København (Copenhagen)
  Country Denmark
Organisations Organisation Apogenix AG
  Organisation 2 Jefferies International Ltd.
  Group Leucadia (Group)
Products Product BioEquity Europe 2016 Copenhagen
  Product 2 Jefferies 2016 Global Healthcare Conference New York
Index terms Index term Apogenix–Informa: investor conference, 201605 supply service Apogenix presents at BioEquity Europe 2016 in Copenhagen
  Index term 2 Apogenix–Leucadia: investor conference, 201606 supply service Apogenix presents at Jefferies Healthcare Conference in New York
Persons Person Höger, Thomas (Apogenix 200511– CEO + CFO before since 10/00 DZ Bank before BASF/Knoll)
  Person 2 Middleman, Matt (LifeSci Public Relations 201712 Founding Partner before Russo Partners LLC 201512)

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that Chief Executive Officer Thomas Hoeger, Ph.D., will present at Bio€quity Europe 2016 and at the Jefferies 2016 Healthcare Conference.

Bio€quity Europe 2016
Venue: Scandic Hotel, Copenhagen, Denmark
Presentation: May 10, 2016, 4:40 p.m. CEST, Ball Room 2

Jefferies 2016 Healthcare Conference
Venue: New York City, NY, USA
Presentation: June 7, 2016, 8:00 a.m. EDT

About Apogenix

Apogenix develops innovative immuno-oncology therapeutics for the treatment of cancer and other malignant diseases. The company has built a promising pipeline of immuno-oncology drug candidates that target different tumor necrosis factor superfamily (TNFSF)-dependent signaling pathways, thereby restoring the immune response against tumors. Since its inception in fall 2005, Apogenix has raised more than 90 million euros in financing rounds, public grants, as well as upfront and milestone payments from licensing agreements. The company is based in Heidelberg, Germany.


Thomas Hoeger, Ph.D., CEO
Apogenix AG
Phone: +49 (6221) 58 60 80

Media Contacts

Matt Middleman, M.D.
Russo Partners, LLC
Phone: +1 (212) 845 4272

Raimund Gabriel
MC Services AG
Phone: +49 (89) 210 228 30

Record changed: 2017-07-02


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg iito 600x60px

More documents for Apogenix AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top